Pro Te: Solutio - Vol. 3, No. 4 - October 2010


In this issue: FDA Warning And Untitled Letters - Using Historical Reference To Avoid Receiving Them In The Future; Healthcare Reform - Actions That Can Be Implemented Today To Prepare For Changes; Generic Preemption After Levine; Are Your Meta Tags Showing?; and more.

Healthcare reform and burgeoning social media are only two of the challenges faced by today’s pharmaceutical, medical device, and healthcare industry. This issue of Pro Te: Solutio offers suggestions for navigating the changing landscape of federal law and regulations.

The broadest, most discussed change this year is healthcare reform. Though the full impact of health-care reform will not be felt for some time, physicians should begin the transition now, taking advantage of opportunities the law offers while avoiding potential pitfalls. Healthcare Reform:

Physicians Should Act Today to Save Tomorrow shares information about steps physicians and physicians’ practices can take right now in three major areas. You’ve Been Warned: FDA Warning and Untitled Letters outlines what a company can do to avoid the sur-prise of receiving Warning letters and Untitled letters from the FDA — and when such a letter is delivered, how to avoid further actions. Are Your Meta Tags Showing? discusses the ins and outs of using the internet and social media to market FDA-regulated products.

Please see full publication below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Butler Snow LLP | Attorney Advertising

Written by:


Butler Snow LLP on:

Popular Topics
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.